Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres

Temozolomide is the current first-line treatment for glioblastoma patients but, because many patients are resistant to it, there is an urgent need to develop antitumor agents to treat temozolomide-resistant glioblastoma. Gossypol, a natural polyphenolic compound, has been studied as a monotherapy or...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hee Yeon, Lee, Byung Il, Jeon, Ji Hoon, Kim, Dong Keon, Kang, Seok-Gu, Shim, Jin-Kyoung, Kim, Soo Youl, Kang, Sang Won, Jang, Hyonchol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843396/
https://www.ncbi.nlm.nih.gov/pubmed/31658771
http://dx.doi.org/10.3390/biom9100595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843396/
https://www.ncbi.nlm.nih.gov/pubmed/31658771
http://dx.doi.org/10.3390/biom9100595

Ejemplares similares